Full Product Details
Author: Franz F. Hefti (Rinat Neuroscience Corporation, Palo Alto, CA)
Publisher: John Wiley & Sons Inc
Imprint: Wiley-Liss Inc.,U.S.
Dimensions:
Width: 17.90cm
, Height: 1.80cm
, Length: 25.70cm
Weight: 0.567kg
ISBN: 9780471465638
ISBN 10: 0471465631
Pages: 328
Publication Date: 19 November 2004
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Out of stock
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.
Reviews
It is a book I enjoyed reading; it is both expression and science. (Journal of Natural Products, October 2005) ...an outstanding overview of the current state of drug discovery... (Drug Development and Industrial Pharmacy, No. 10, 2005) ...handy for old-timers who need a quick refresher on current therapy for neurological disorders. (Current Separations, August 2005) ...highly readable and informative. The entire book is carefully organized and very well written. It provides an excellent resource... (American Journal of Pharmaceutical Education, Volume 69, Issue 4, 2005) ...recommended for all practitioners and advanced students who have an interest in this field. (E-STREAMS, August 2005) ...unique in providing an overview and synthesis of the current state of research on diseases of the nervous system, relevant pharmacological principles, and...the drug discovery process. (Doody's Book Review Service) The text gives an overview of the state of current research, but also gives an outlook on possible future drug targets. (Drug Discovery & Development, February 2005) ...a marvelous text that offers the medical community a new perspective on both treatment and research... (Electric Review, November 2004)
Author Information
Franz F. Hefti, PhD, held academic positions between 1985 and 1995, first as Associate Professor at the University of Miami, Florida, than as Professor with endowed chair at the University of Southern California in Los Angeles. He conducted pioneering research in the area of neurotrophic factors by demonstrating that these proteins can rescue dying nerve cells in the adult brain. He has served as Director of Neuroscience Research at Genentech Inc., pursuing industrial applications of his research on neurotrophic factors, leading to phase III trials with nerve growth factor. Since 1995 his activities have been dedicated to the discovery of novel drugs for neurological and psychiatric diseases in the pharmaceutical industry. From 1995 to 2001 he was Vice President at Merck Research Laboratories and Director of The Neuroscience Research Centre of Merck Sharp & Dohme. He later served as Senior Vice President of Neuroscience Research at Merck & Co.
